On May 9, the United States Food and Drug Administration (FDA) announced the successful completion of a pilot project for a new generative AI system aimed at scientific reviewers. Following this milestone, the FDA has embarked on a comprehensive internal deployment of artificial intelligence, aiming to fully integrate AI across all its subordinate centers by June 30.
